<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>XM-DAC-41114-OUTPUT-00115227</iati-identifier>
  <reporting-org ref="XM-DAC-41114" type="40">
   <narrative xml:lang="EN">United Nations Development Programme</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Support SFDA Third Strategic P</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">This nationally executed project aims at providing advisory services, specialized experts, and administrative support to SFDA</narrative>
  </description>
  <participating-org ref="00210" role="1" type="10">
   <narrative xml:lang="EN">GOVERNMENT OF SAUDI ARABIA</narrative>
  </participating-org>
  <participating-org ref="02751" role="4" type="10">
   <narrative xml:lang="EN">Saudi Food and Drug Authority</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-04-01" type="1"></activity-date>
  <activity-date iso-date="2019-04-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <email>registry.sa@undp.org</email>
   <website>http://www.sa.undp.org/</website>
  </contact-info>
  <activity-scope code="8"></activity-scope>
  <recipient-country code="SA" percentage="100">
   <narrative xml:lang="EN">Saudi Arabia</narrative>
  </recipient-country>
  <location ref="SA">
   <location-reach code="1"></location-reach>
   <location-id code="108410" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Riyadh</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">capital of a political entity</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">Capital</narrative>
   </activity-description>
   <administrative code="108410" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>24.687730 46.721850</pos>
   </point>
   <exactness code="1"></exactness>
   <location-class code="2"></location-class>
   <feature-designation code="PPLC"></feature-designation>
  </location>
  <sector code="17" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Eradicate poverty in all its forms and dimensions</narrative>
  </sector>
  <sector code="10.1" percentage="33.33" vocabulary="8"></sector>
  <sector code="15144" percentage="100" vocabulary="1"></sector>
  <sector code="16.6" percentage="33.33" vocabulary="8"></sector>
  <sector code="17.14" percentage="33.33" vocabulary="8"></sector>
  <tag code="10.1" vocabulary="3"></tag>
  <tag code="16.6" vocabulary="3"></tag>
  <tag code="17.14" vocabulary="3"></tag>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="4"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2019-12-31">4000000</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2020-12-31">1740241</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-12-31">4085646</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-05-31">5706898</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">4000000</value>
   <provider-org ref="00210" type="10">
    <narrative xml:lang="EN">GOVERNMENT OF SAUDI ARABIA</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00115227" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1599787</value>
   <provider-org ref="00210" type="10">
    <narrative xml:lang="EN">GOVERNMENT OF SAUDI ARABIA</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00115227" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1740241</value>
   <provider-org ref="00210" type="10">
    <narrative xml:lang="EN">GOVERNMENT OF SAUDI ARABIA</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00115227" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">1599787</value>
   <provider-org ref="00210" type="10">
    <narrative xml:lang="EN">GOVERNMENT OF SAUDI ARABIA</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00115227" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">4085646</value>
   <provider-org ref="00210" type="10">
    <narrative xml:lang="EN">GOVERNMENT OF SAUDI ARABIA</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00115227" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">5706898</value>
   <provider-org ref="00210" type="10">
    <narrative xml:lang="EN">GOVERNMENT OF SAUDI ARABIA</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00115227" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">2769717</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1723142</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-01-31"></transaction-date>
   <value currency="USD" value-date="2021-01-31">60961</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-02-28"></transaction-date>
   <value currency="USD" value-date="2021-02-28">68119</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">157753</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">256629</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-05-31"></transaction-date>
   <value currency="USD" value-date="2021-05-31">105453</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">152469</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">104236</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-08-31"></transaction-date>
   <value currency="USD" value-date="2021-08-31">135803</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-09-30"></transaction-date>
   <value currency="USD" value-date="2021-09-30">211300</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-10-31"></transaction-date>
   <value currency="USD" value-date="2021-10-31">227693</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-11-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">294158</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">334094</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-02-28"></transaction-date>
   <value currency="USD" value-date="2022-02-28">70057</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-03-31"></transaction-date>
   <value currency="USD" value-date="2022-03-31">131291</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">65410</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">12308426</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">116176</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2022-06-15"></transaction-date>
   <value currency="USD" value-date="2022-06-15">20928</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="EN">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <document-link format="TEXT/HTML" url="http://open.undp.org/projects/00118398">
   <title>
    <narrative xml:lang="EN">Activity web page</narrative>
   </title>
   <category code="A12"></category>
  </document-link>
  <related-activity ref="XM-DAC-41114-PROJECT-00118398" type="1"></related-activity>
  <conditions attached="1">
   <condition type="1">
    <narrative xml:lang="EN">Social and environmental sustainability will be enhanced through application of the UNDP Social and Environmental Standards (http://www.undp.org/ses) and related Accountability Mechanism (http://www.undp.org/secu-srm).</narrative>
   </condition>
  </conditions>
  <result aggregation-status="1" type="1">
   <title>
    <narrative xml:lang="EN">Annual Output Results</narrative>
   </title>
   <indicator ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">Output Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">1.1 National HTA guidelines
1.2 Expert visits to support SFDA in building capacities
2.1 Quality assurance practice documents 
2.2 Report on assessment of health technologies used at healthcare providers in order to ensure their quality and safe use</narrative>
    </description>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Saudi Food and Drug Authority completed the implementation of its First Strategic Plan for 2007-2011 and its Second Strategic Plan for 2012-2016</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">1. Develop drug and medical devices safety and security assessment.
2. Develop risk-based and safe use assessment. 
3. Build and develop institutional and human capacities. 
4. Promote international cooperation and presence. 
5. Improve internal communication and corporate culture.</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">1. 
- Contributing to building and developing the national drug safety database.
- Ensuring the efficiency and safety of medical devices and products and that medical claims of the medical device / product are based on scientific evidence that supports the purpose for which it was made. Moreover, we ensure the provision of scientific opinion by specialists and qualified persons in a number of medical fields as the lack of scientific advice may increase the potential risks to society regarding the safety and efficacy of medical devices and products.
- Several health, governmental and educational bodies worked to participate in the specifications of medical devices and products, and benchmarking the relevant international standardization committees, aiming to study standardization projects at the local, regional and international levels in the following areas:
(Optics devices - medical electrical devices - quality of medical devices - health informatics - anesthesia and breathing devices - biological products and clinical studies - implanted medical devices - medical tissue products)
- Finalizing the determination of reference levels for CT scans for adults and children.
- Contributing to building and developing the national drug safety database.
- Discussing and providing clinical scientific advice regarding the calculation of AstraZeneca vaccine doses related to clinical studies submitted at the time of registration. Discussing the process of transferring the manufacture of vaccines using adenovirus vector technology from the clinical scientific side and holding five development workshops to manage benefits and risks assessment.
- Assisting in evaluation of clinical trials of COVID-19 vaccines submitted for registration.
- Providing technical advice on evaluating the analysis and stability of biological drugs.
- Publishing the guidelines of electronic requirements for veterinary preparations, revising registered preparations, creating a database of active substances and creating a database of medicines with a unified code.
- Providing technical advice on advanced treatments.
- Providing technical advice on COVID-19 vaccines, especially mRNA.
- Providing consultations and preparing a scientific program on cosmetic products claims.
- Providing the scientific opinion for the requirements of the vaccine manufactured by the Indian SII and the need of submitting clinical comparative immunogenicity studies and consultations on the use of COVID-19 vaccine in children and on the use of a booster shot.
- Developing and activating vaccines trend analysis.
- Providing scientific consultations, training programs and workshops specialized in scientific evaluation.
- Providing observations and inputs about some medical devices&#x2019; clinical evaluation studies.
2.
- Guideline for consumption of products containing caffeine.
- Guideline for pilgrims feeding.
- A narrative review and analysis of the content of individual food consumption analysis applications.
- The second scientific statement issued by the National Nutrition Committee regarding the effect of caffeine consumption on health status.
- The scientific content to activate the Gulf Nutrition Week.
- Activating the awareness content of National Nutrition Committees account during the month of Ramadan and the days of Eid Al-Fitr.
- Activating the awareness content of National Nutrition Committees account during the Hajj season.
- A report on the study of the impact of COVID-19 on the extent of attention to the calorie content of restaurant meals.
- A scoping review of the most important applications of individual food consumption analysis.
- A report of the study &#x201C;food allergy prevalence in Saudi society and the most significant challenges facing people with it.
- Infographic of the study &#x201C;food allergy prevalence in Saudi society and the most significant challenges facing people with it.
- Providing scientific opinions for studies of acute and chronic toxicity and pesticides effect on mutating fetuses and the effect of such pesticides on aquatic organisms, fish and bees.
Participating in the study of international standards approved by the regulators for classification of active substances by carcinogenic potential.
- Contributing to and supporting the implementation of the food safety systems maturity assessment project in the kingdom.
- Participating in research studies on potential toxicities in camel fodder.
- Participating in research studies on the use of bread residues from households and bakeries to feed animals.
- Contributing to and supporting the implementation of the food safety systems maturity assessment project in the kingdom.
3.
- Provide coaching sessions for SFDA leaders.
- Provide training for employees of the clinical trials and studies departments
- Provide a training program on the foundations of writing scientific reports and articles
- Train the employees of the Biological Products Assessment Department on risk assessment and analysis of advanced treatments
- A scientific program was presented for the Biological Products Assessment Department&#x2019;s employees to assess risks and analyses of manufacturing methods for the COVID mRNA vaccines.
- A scientific program was presented to the Cosmetics Safety Department staff on the claims about cosmetics and considering the evidence required to prove and how to verify the cosmetics.
- A scientific program was presented to the employees about scientific criticism of scientific reports and training researchers on scientific research skills
- A program was presented on a systematic review of the primary research sampling.
- A program was presented about reviewing the methodology of the descriptive research study, as well as data analysis
- Provide training workshops on risk assessment and post-marketing control of medical devices.
- Hold workshops on the mechanism of evaluating and considering the technical file of diagnostic laboratory devices and the regulatory affairs of diagnostic laboratory devices.
4.
- SFDA, represented by Food Sector, participated in the seventh meeting of the International Risk Communication Liaison Group (IRCLG).
- Drugs Sector, represented by the Drugs Quality Executive Directorate, participated through video-conference in the regional meeting of United States Pharmacopeia (USP) at the level of the Middle East and North Africa region.
- SFDA participated in Expo Dubai 2020 in the United Arab Emirates by giving a presentation on GCC Food Safety Standing Committee&#x2019;s role in the pavilion of General Secretariat of Gulf Cooperation Council, coinciding with the World Food Day.
- SFDA won Jeddah Innovation Award in its fourth edition.
- SFDA participated in the International Conference on Drug Regulatory Authorities (ICDRA)
- SFDA won the Arab Government Excellence Award for the best Arab government agency or institution.
- Drugs sector participated in a workshop as part of the World Drug Safety Week 2021 &#x201C;Vaccines Safety&#x201D; awareness campaign.
- SFDA, represented by the Medical Devices and Medical Products Sector, participated in the Breast Cancer Awareness Event &amp; Pink Salon
- SFDA organized the sixteenth meeting of the Gulf Technical Committee for Standardization of Medical Devices and Supplies (GSO TC 11) via video-conference.
- Research and Laboratories Sector Participated in the 20th annual meeting of the International Society for Pharmacovigilance, which was held in Muscat, Sultanate of Oman.
- SFDA participated in the general assembly meetings of representatives and coordinators of member states in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals via video conference.
- The Kingdom of Saudi Arabia, represented by SFDA, organized the twenty-fifth meeting of the Global Harmonization of Medical Devices, digital transformation in medical device regulations, and the latest updates of relevant international organizations.
- SFDA won King AbdulAziz Quality Award.
5. 
- Establish a change management methodology in SFDA and deliver workshops and lectures in the field of change management.
- Deliver general lectures to all SFDA employees to raise awareness of change management
- Deliver a workshop for project managers in the Drugs Sector on the application of change management to projects
- Co-attend meetings with change leaders and project managers for guidance, support, and provide advice on everything related to change management.
- Design the framework based on ADKAR methodology and provide SFDA with the necessary tools and models based on SFDA characteristics and requirements.
- Deliver a training workshop for SFDA-nominated change leaders.
- Deliver a workshop on leadership empowerment.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Develop HTA guidelines for technologies relevant for SFDA, i.e. drug and medical devices</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">inspection staff were well trained and well informed with respect to the context of the sample collection and that they can provide feedback on any constraints or difficulties they encounter during sample collection. A technical assistance to SFDA was provided in revising the Integrated Annual National Monitoring and Control Plan with the aim of becoming more risk based. Data documenting previous sampling results were collated, cleaned and summarised, to provide an indication of the contamination levels found and thus to inform future sampling efforts. Data sets were based around food-borne hazard categories, including: Microbiology; Pesticides; Veterinary Residues; Contaminants and Quality Tests.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Development of safety and safety assessment of medicines and medical devices</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">&#x2022;	Update six internal pharmaceutical preparations bulletins regarding drug safety. 
&#x2022;	 Requesting additional information from nine marketed companies regarding drug safety. 
&#x2022;	Update the list of analyzed pesticides, activate the analysis of tobacco samples, and address some technical problems
&#x2022;	A plan has been made to establish a specialized center to supply competency samples, in partnership with colleagues in the Laboratory Development Center
&#x2022;	Distributing warning messages to health care providers for one product</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">- Strengthening the authority&#x2019;s role and vision in the international community. 
- Hiring CTA for the project. 
- Recruiting two food and drug experts. 
- Recruitment of two experts in communication and international cooperation.
- Providing capacity building of the SFDAs staff in the area of communication and international cooperation.
- Activating the practical training programmes and secondment programmes of international organizations.
- Developing partnerships with leading academic organizations that offer specific, qualitative programs.
- Producing data Gap analysis on food safety risks.</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN"></narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
